Navigation Links
Use of Insecticides Linked to Lasting Neurological Problems for Farmers

New research shows that farmers who used agricultural insecticides experienced increased neurological symptoms, even when they were no longer using the products. Data from 18,782 North Carolina and Iowa farmers linked use of insecticides, including organophosphates and organochlorines, to reports of reoccurring headaches, fatigue, insomnia, dizziness, nausea, hand tremors, numbness and other neurological symptoms. Some of the insecticides addressed by the study are still on the market, but some, including DDT, have been banned or restricted.

These findings will be available online in April, and published in the June issue of Environmental Health Perspectives. The research is part of the ongoing Agricultural Health Study funded by the National Institute of Environmental Health Sciences and the National Cancer Institute, two of the National Institutes of Health, and the Environmental Protection Agency.

"This research is really important because it evaluated the health effects of agricultural chemicals as they were commonly used by farmers. It's different from previous studies that focused on pesticide poisoning or high dose exposures, for example when large amounts of a chemical were accidentally spilled on the skin," said Freya Kamel, Ph.D., a researcher for the National Institute of Environmental Health Sciences (NIEHS).

The NIEHS researchers examined questionnaires completed by farmers on lifetime exposure to herbicides, insecticides, fungicides, and fumigants, and their history of 23 neurological symptoms. Those who reported experiencing more than 10 symptoms during the year prior to completing a study questionnaire were classified as having high levels of symptoms.

Researchers found that nearly 3,000 participants had a high lifetime exposure to insecticides ?that is, they used insecticides more than 500 days in their lifetime. Nearly 800 of these farmers reported more than 10 neurological symptoms compared to those using insecticide s fewer than 50 days. The researchers found no significant association between neurological symptoms and other chemicals, including herbicides or fungicides, and only a weak association between fumigant exposure and neurological symptoms.

Some of the insecticides used by the licensed farmers over the past 25 years are no longer available commercially. DDT, a well known example of an organochlorine, has been banned for use in the US since 1972. Organophosphates, such as malathion, chlorypyrifos, and diazinon, have been banned or restricted for home and garden use in the US. However, some of the pesticides examined, including carbaryl and some pyrethroids, are available to home gardeners, although in different formulations and in lower concentrations, which may make them less hazardous.

"Because the participants in this study are telling us they have never been previously diagnosed with pesticide poisoning or medically treated for any exposure to any pesticide, we are led to conclude that their symptoms are related to moderate lifetime exposure," said Dr. Kamel.

"Most studies of this issue have sample sizes ranging from 50 to 100 participants, making it hard to understand the detailed relationship between exposure and health effects. The large size of this study gives it great statistical power," said Dr. Kamel.

The AHS ( is designed to investigate the effects of environmental, occupational, dietary, and genetic factors on the health of the agricultural population. The study will provide information that agricultural workers can use in making decisions about their health and the health of their families.



Related biology news :

1. Spider Venom Could Yield Eco-Friendly Insecticides
2. New SARS Protein Linked To Important Cell Doorway
3. Breast-Cancer Risk Linked to Exposure to Traffic Emissions at Menarche, First Birth
4. Nighttime Dying Linked To Sleep Apnea From Brain Cell Loss
5. Defective Gene Linked to Two Inherited Immune Deficiencies
6. HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs
Post Your Comments:

(Date:5/12/2016)... 12, 2016 , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), ... free webinar on Performing Quality Investigations: Getting to Root Cause. ... no charge. , Incomplete investigations are still a major concern to the Regulatory ...
Breaking Biology Technology: